Local manufacturer plans to redevelop Journal Sentinel's closed printing plant with 1,000 jobs
Global Power Components wants to buy the building, at 4101 W. Burnham St., West Milwaukee, and construct a large addition for its growing operations.
That's according to information disclosed May 9 by the West Milwaukee Plan Commission. The commission is to consider Global Power's proposal at its May 13 meeting.
Global Power has outgrown its main facility at 2300 S. 51st St., said John Stalewski, village president.
He told the Journal Sentinel the company plans to still maintain that operation on Milwaukee's south side.
Global Power, known formally as BHP Inc., builds fuel tanks, enclosures and other equipment for the power generation industry.
"Apparently, stand-by generators have gotten to be a big business," Stalewski said.
He said Global Power says the West Milwaukee plant would have three production shifts totaling around 1,000 employees.
Global Power currently operates in five Milwaukee-area facilities with more than 1,200 employees, according to the Plan Commission documents.
"We're very excited about this project," Stalewski said. He said the development could include village funding through a possible tax incremental financing district.
The West Milwaukee plant, along with the company's Milwaukee facilities, "will help us serve our customers with industry-leading innovation and design," said Chief Operating Officer Mike Watkinson, in a statement.
The Journal Sentinel's 476,316-square-foot former production facility is listed for leasing, and for sale, by Colliers, a commercial real estate services provider. The listed sale price is $27.5 million.
Global Power wants to build a 230,000-square-foot addition to provide more manufacturing space, according to the Plan Commission documents.
The news organization's corporate parent, Gannett Co., closed the production facility in 2022 as a cost-savings move − eliminating 180 jobs. The Journal Sentinel is now printed at a Gannett plant in Peoria, Illinois.
The $112 million West Milwaukee printing plant opened in 2003.
The property was sold in 2022 for $26 million to 4101 W. Burnham St. Milwaukee WI LLC.
That's an affiliate of New York-based Alden Global Capital LLC − an investment firm that owns newspapers, including the Chicago Tribune.
But Alden Global's apparent plans to print the Chicago Tribune in West Milwaukee never materialized.
Global Power's plans were disclosed around one year after the maker of Palermo's frozen pizzas announced plans to expand through a new West Milwaukee production facility with 50 jobs.
Palermo Villa Inc.'s new operation is being developed at 3900 W. Lincoln Ave. That was the longtime site of Froedtert Malt Corp.'s complex before it was demolished in 2023.
(This story was updated to provide new information).
Tom Daykin can be emailed at tdaykin@jrn.com and followed on Instagram, Bluesky, X and Facebook.This article originally appeared on Milwaukee Journal Sentinel: Global Power to bring 1,000 jobs to former Journal Sentinel facility
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Sculpt By Science Unveils Exclusive Program to Empower CEOs and Entrepreneurs with Peak Performance
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Sculpt By Science introduces a groundbreaking health program designed to help CEOs, entrepreneurs, and business leaders optimize their well-being, leading to enhanced professional success. Sculpt By Science Introduces Life-Changing Health Program for High-Performing Business Leaders Sculpt By Science, the leading health and fitness brand founded by Dr. Michael Gino Diamonds, is redefining how entrepreneurs and CEOs approach their health and well-being. With the launch of their exclusive DNA Sequence program, the company is offering a groundbreaking solution to help business leaders achieve not only optimal physical health but also peak mental performance, ensuring they thrive both in the boardroom and DNA Sequence program is designed for those who view health as a strategic investment, recognizing the deep connection between physical fitness and professional success. Sculpt By Science takes a unique approach that integrates medical diagnostics, fitness science, and behavior change psychology, offering high-performance solutions for entrepreneurs who demand the best in all areas of their lives. The Link Between Health and Business Success Business leaders, especially those in high-pressure environments, often face the dilemma of balancing long working hours with the need to maintain their physical and mental well-being. Sculpt By Science addresses this challenge by offering a health program that is as much about mental clarity and focus as it is about physical fitness. "Health is the foundation of success in business, but too often, executives neglect it in the pursuit of their goals," said Dr. Michael Diamonds, Founder of Sculpt By Science. "The DNA Sequence program is designed to help high performers unlock their full potential by integrating science-backed health strategies into their busy lives. When you feel better, you perform better, this is what we're proving with every client we serve." Personalized Plans with a Focus on Peak Performance Sculpt By Science's DNA Sequence program goes beyond traditional fitness plans by offering a tailored approach for each client, starting with a comprehensive health assessment. This includes advanced testing, such as hormone analysis, gut health mapping, and DEXA scans, that ensures each program is uniquely suited to the client's needs. From there, a personalized fitness and wellness plan is created, taking into account the client's lifestyle, goals, and challenges. The program incorporates everything from physical training to stress management, sleep optimization, and nutritional guidance, all while aligning with the fast-paced schedules of busy professionals. One key feature of the program is its emphasis on identity transformation. Rather than simply focusing on temporary results, Sculpt By Science helps clients cultivate the mindset of a "Business Athlete." This concept encourages executives to treat their bodies as their most important asset, investing in their health the same way they would in their businesses. "The transformation is not just about losing weight or getting stronger," Dr. Diamonds explained. "It's about shifting the way our clients think about themselves. A Business Athlete understands that true success requires optimal health, and the DNA Sequence program is the pathway to unlocking that potential." Exclusive Support and Community for High Performers In addition to personalized health plans, the DNA Sequence program offers an unparalleled level of support. Clients gain access to weekly one-on-one consultations with Dr. Diamonds and his team of medical professionals, as well as 24/7 messaging support. This ensures that clients stay on track and can make adjustments as needed in real-time. The program also fosters a close-knit community of like-minded business leaders who are committed to achieving their best health. Sculpt By Science offers exclusive mastermind groups and private retreats, creating opportunities for clients to network, share experiences, and collaborate with others who share similar goals. "Our clients don't just get a fitness plan, they get a community of high achievers who are all focused on achieving peak performance," said Dr. Diamonds. "The mastermind events and private retreats give our clients the opportunity to connect with others who understand the pressures of leading a business. It's a place where they can learn, grow, and be inspired." Real Results for Busy Professionals Sculpt By Science is already seeing incredible success with its DNA Sequence program, having helped over 2,000 clients transform their health and business performance. High-profile entrepreneurs, CEOs, and executives have experienced life-changing results, from fat loss and muscle gain to improved energy and mental clarity. One client, a Silicon Valley entrepreneur, shared: "The DNA Sequence program didn't just help me lose weight, it gave me the energy and clarity to lead my company to new heights. I've never felt this focused and confident in my business." Another client, a CEO, said: "Before Sculpt By Science, I struggled with maintaining my health while managing my business. Now, I feel stronger, healthier, and more driven than ever. My physical health has truly become the foundation of my business success." The Future of Executive Health Sculpt By Science's DNA Sequence program is setting a new standard for health and fitness in the business world. As the program continues to gain momentum, more and more entrepreneurs and executives are realizing the direct connection between health optimization and business success. "We believe that health is the ultimate competitive edge," Dr. Diamonds said. "By optimizing physical health and mental performance, our clients are able to lead their businesses with clarity, focus, and confidence. This is the future of executive health, and we're excited to be at the forefront of this movement." For more information about Sculpt By Science and how to apply for the DNA Sequence program, visit About Sculpt By Science Sculpt By Science is a premium health and fitness brand focused on helping high-performing entrepreneurs, CEOs, and business leaders optimize their health for peak performance. Founded by Dr. Michael Diamonds, a medical doctor and fitness expert, Sculpt By Science combines advanced diagnostics with personalized fitness plans to deliver transformative results. With over 2,000 clients served, Sculpt By Science is helping executives unlock their full potential and achieve sustained success. Media Contact: Dr. Michael Gino DiamondsFounder & CEO, Sculpt By ScienceEmail: mikediamonds23@ Website: @DoctorMikeDiamondsInstagram: @ Disclaimer: This press release is provided by Sculpt By Science. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing involves significant risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Legal Disclaimer: This media platform provides the content of this article on an "as-is" basis, without any warranties or representations of any kind, express or implied. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above. A photo accompanying this announcement is available at while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Upturn
an hour ago
- Business Upturn
JSW Cement lists at Rs 153.50, posts 4.4% gains over IPO price
Shares of JSW Cement made a positive debut on Monday, listing at ₹153.50 apiece — up 4.42% from the upper end of its IPO price band of ₹147. The Mumbai-based cement maker's IPO, open from August 7 to August 11, was priced in the range of ₹139-147 per share with a lot size of 102 shares. The company raised ₹3,600 crore, comprising a fresh issue of ₹1,600 crore and an offer-for-sale of ₹2,000 crore (13.60 crore shares). The issue saw an overall subscription of 7.77 times, with QIBs subscribing 15.80 times, NIIs 10.97 times, and retail investors 1.81 times. Employee quota was also fully subscribed. Analysts note that the brand's strong recall and stable demand outlook helped deliver a good listing despite modest oversubscription. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Insider
an hour ago
- Business Insider
COHR Earnings: Coherent Stock Crashes 16% on Disappointing Guidance
The stock of Coherent (COHR) is down 16% after the semiconductor company reported revenue guidance that disappointed Wall Street. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The Pennsylvania-based company announced earnings per share (EPS) of $1, which topped the $0.92 expected among analysts. Revenue for the year's second quarter totaled $1.53 billion, which was ahead of the $1.51 billion forecast on Wall Street. Sales were up 16% from a year earlier. Unfortunately, Coherent's revenue guidance overshadowed what was otherwise a strong print from the optical materials and semiconductor concern. For the current quarter, Coherent said that it expects revenue of $1.53 billion, which is basically the same as sales generated in Q2 of this year and is 0.6% below analysts' consensus estimate. Laser Business Sale Coherent's networking business unit saw its revenue rise 39% year-over-year in calendar Q2 to $945 million, above expectations for $940 million in sales. That strong showing was partially offset by the company's other two business lines, materials and lasers, which were down a combined 8% in the quarter. Just before Coherent's latest earnings were released after markets closed, the company announced the sale of its laser business for defense markets at a price of $400 million. Money generated from the sale will be used to pay down the company's $3.7 billion in debt. Is COHR Stock a Buy? The stock of Coherent has a consensus Strong Buy rating among 15 Wall Street analysts. That rating is based on 14 Buy and one Hold recommendations issued in the last three months. The average COHR price target of $105.31 implies about 8% downside risk from current levels. These ratings are likely to change after the company's financial results.
